Log In
Print
BCIQ
Print
Print this Print this
 

Avastin, bevacizumab (RG435)

Also known as: Anti-VEGF antibody (R435)

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionHumanized mAb against VEGF
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today